Related Experiment Video
Updated: Mar 16, 2026

07:41
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
2.5K
Right Ventricular Function in Patients With Left Ventricular Assist Device Support by Pulsatile Polvad MEV and
P Nadziakiewicz1, J Borkowski1, B Szygula-Jurkiewicz2
1Department of Cardiac Anesthesia and Intensive Care SUM, Silesian Center for Heart Diseases, Zabrze, Poland.
Transplantation Proceedings
|August 7, 2016
Summary
Continuous-flow pumps optimize right ventricular function better than pulsatile devices in heart failure patients. This finding suggests improved prevention of right ventricular failure with continuous-flow left ventricular assist devices (LVADs).
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Left ventricular assist device (LVAD) support is crucial for advanced heart failure.
- The right ventricle (RV) is critical for LVAD support, but its response to different LVAD types is not well understood.
- Pulsatile and continuous-flow LVADs may have differential impacts on RV function.
Purpose of the Study:
- To compare the effects of pulsatile Polvad MEV (PM) versus continuous-flow Heartware (HW) or Heartmate II (HMII) left ventricular assist devices (LVADs) on right ventricular (RV) hemodynamic parameters.
- To evaluate RV function post-implantation in patients receiving different types of LVADs.
Main Methods:
- Retrospective review of 44 heart failure patients who received either PM (n=24) or HW/HMII (n=20) LVADs.
- Collected hemodynamic data included mean pulmonary artery pressure (mPAP), central venous pressure (CVP), cardiac output (CO), and cardiac index (CI).
- Calculated right ventricular work (RVW) using established hemodynamic parameters before and after LVAD implantation.
Main Results:
- While baseline characteristics were similar, patients with continuous-flow LVADs (group C) showed significantly higher cardiac output and index post-implantation compared to the pulsatile group (group P).
- Central venous pressure (CVP) was higher in group P, and post-implantation right ventricular work (RVW) was significantly higher in group C at multiple time points.
- Continuous-flow pumps demonstrated a more favorable hemodynamic profile for RV support.
Conclusions:
- Continuous-flow LVADs appear to optimize right ventricular function more effectively than pulsatile LVADs.
- This optimization may lead to better prevention of right ventricular failure or insufficiency in patients supported by continuous-flow devices.

